Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| PFIZER INC | 97,679 | reported | 28 Apr 2011 | tx 8+36,326 |
| REGENERON PHARMACEUTICALS, INC. | 1,703 | reported | 02 Jan 2026 | tx 427+613,025−744,753 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 02 Jan 2026 | GRANT_AWARD | REGENERON PHARMACEUTICALS, INC. | 155 | 0.00 USD | |
| 02 Jan 2026 | GRANT_AWARD | REGENERON PHARMACEUTICALS, INC. | 1,962 | 0.00 USD | deriv |
| 02 Jan 2025 | GRANT_AWARD | REGENERON PHARMACEUTICALS, INC. | 166 | 0.00 USD | |
| 02 Jan 2025 | GRANT_AWARD | REGENERON PHARMACEUTICALS, INC. | 1,958 | 0.00 USD | deriv |
| 14 Jun 2024 | EXERCISE | REGENERON PHARMACEUTICALS, INC. | 1,535 | 625.60 USD | |
| 14 Jun 2024 | SALE | REGENERON PHARMACEUTICALS, INC. | 1,535 | 1040.00 USD | |
| 14 Jun 2024 | EXERCISE | REGENERON PHARMACEUTICALS, INC. | 1,535 | 0.00 USD | deriv |
| 28 May 2024 | EXERCISE | REGENERON PHARMACEUTICALS, INC. | 1,172 | 625.60 USD | |
| 28 May 2024 | SALE | REGENERON PHARMACEUTICALS, INC. | 1,172 | 974.86 USD | |
| 28 May 2024 | EXERCISE | REGENERON PHARMACEUTICALS, INC. | 1,172 | 0.00 USD | deriv |
| 02 Jan 2024 | GRANT_AWARD | REGENERON PHARMACEUTICALS, INC. | 135 | 0.00 USD | |
| 02 Jan 2024 | GRANT_AWARD | REGENERON PHARMACEUTICALS, INC. | 1,607 | 0.00 USD | deriv |
| 27 Dec 2023 | SALE | REGENERON PHARMACEUTICALS, INC. | 2,049 | 898.00 USD | |
| 27 Dec 2023 | EXERCISE | REGENERON PHARMACEUTICALS, INC. | 2,049 | 482.68 USD | |
| 27 Dec 2023 | EXERCISE | REGENERON PHARMACEUTICALS, INC. | 2,049 | 0.00 USD | deriv |
| 21 Apr 2023 | EXERCISE | REGENERON PHARMACEUTICALS, INC. | 3,070 | 520.01 USD | |
| 21 Apr 2023 | SALE | REGENERON PHARMACEUTICALS, INC. | 3,070 | 798.42 USD | |
| 21 Apr 2023 | EXERCISE | REGENERON PHARMACEUTICALS, INC. | 3,070 | 0.00 USD | deriv |
| 06 Feb 2023 | SALE | REGENERON PHARMACEUTICALS, INC. | 3,071 | 798.00 USD | |
| 06 Feb 2023 | EXERCISE | REGENERON PHARMACEUTICALS, INC. | 3,071 | 520.01 USD | |
| 06 Feb 2023 | SALE | REGENERON PHARMACEUTICALS, INC. | 500 | 797.00 USD | |
| 06 Feb 2023 | EXERCISE | REGENERON PHARMACEUTICALS, INC. | 3,071 | 0.00 USD | deriv |
| 27 Jan 2023 | SALE | REGENERON PHARMACEUTICALS, INC. | 1 | 747.00 USD | |
| 27 Jan 2023 | EXERCISE | REGENERON PHARMACEUTICALS, INC. | 1 | 520.01 USD | |
| 27 Jan 2023 | EXERCISE | REGENERON PHARMACEUTICALS, INC. | 1 | 0.00 USD | deriv |